UTHSC In the Media


Remembering Dr. Willis Stanage: Renowned Pediatrician and Mentor

In the Media Icon

Dr. Willis Stanage, a celebrated pediatrician, professor, and mentor, has died at the age of 78, according to a statement from the University of Tennessee Health Science Center.


UT Accelerate Fund invests in PreTel, a medtech company focused on prenatal health

In the Media Icon

PreTel is also the previous first place winner of the PYA Ballard Innovation Award, and recipient of $50,000 worth of cash and in-kind services.


UT Accelerate Fund invests in PreTel, a medtech company focused on prenatal health

In the Media Icon

The University of Tennessee Research Foundation’s (UTRF) Accelerate Fund has invested in PreTel, Inc., a Tennessee-based medical device startup developing wearable sensors to help physicians distinguish true labor from false labor.


PTSD and alcoholism can ruin veterans’ lives. This UTHSC researcher’s solution could one day treat both.

In the Media Icon

In April, behavioral neuroscientist Bryan Cruz was in his office at the University of Tennessee Health Science Center when he received major news: He had received a $749,000 grant from the National Institute on Alcohol Abuse and Alcoholism.


Kenneth Ataga Leads Efforts to Improve Lives of Patients With Sickle Cell Disease

In the Media Icon

Since becoming a doctor, Kenneth Ataga, goals have always been the same: help patients with sickle cell disease live as normal a life as possible.


Ascension Sacred Heart welcomes new cardiologist

In the Media Icon

Ascension Sacred Heart Gulf has welcomed Mark Holt, MD, board-certified in cardiovascular disease and internal medicine, to the medical office building on the Ascension Sacred Heart Gulf campus at 3871 E. Highway 98, Suite 202.


What Is the Role of Immunology in Atopic Dermatitis Care? With Jay Lieberman, MD

In the Media Icon

At RAD2026, Lieberman notes advances in immunology and systemic therapies that are reshaping the link between dermatology and allergy/immunology.


TMS for MDD Is Changing Fast. Here’s What Psychiatrists Need to Know

In the Media Icon

New accelerated TMS protocols and an FDA-approved at-home device are changing how psychiatrists treat MDD after antidepressant failure.